Why Canada's opioid death rate just passed the US — and why the headline misses the story

For nearly a decade the comparison ran the other way. The American opioid crisis was the cautionary tale Canadian commentators pointed at from across the border — a worst case Canada was on track to avoid. In 2024 that stopped being true on a national per-capita basis.

The chart that prompted this article — an r/OpenDataCanada post — showed both numbers honestly: Canada 17.7, United States 16.4, with a small annotation in the corner noting "Canada without BC" comes in at 14.0. That annotation is doing a lot of work. This article is about why.

The numbers

7,313 Canadians died of opioid toxicity in 2024, according to Health Canada's Health Infobase. That's a rate of 17.7 per 100,000 — down from 8,020 deaths in 2023, but still close to three times the number in 2016. The US rate of 16.4 comes from the CDC's Vital Statistics Rapid Release. The two definitions don't line up perfectly, but they're close enough to compare.

The provincial breakdown

British Columbia's rate is more than five times Quebec's, more than ten times Prince Edward Island's, and roughly two and a half times the US national average. Five Canadian jurisdictions — BC, Yukon, Manitoba, Alberta, Saskatchewan — sit above the United States. Every other jurisdiction in the country sits below it.

The national-average framing folds all of that into one number weighted by population. Because BC accounts for about 14 percent of Canada's population at a rate roughly five times the rest-of-Canada figure, it pulls the national average up by about 3.5 points on its own. Strip BC out and the comparison reverses cleanly: Canada-without-BC at 14.0, the US at 16.4.

This is not a minor accounting note. It changes what the chart is actually telling you.

What's happening in BC

BC declared a public health emergency over opioid deaths in April 2016 — the first Canadian jurisdiction to do so. The cause then is the same as now: fentanyl displaced heroin in the unregulated drug supply, and the fentanyl arriving in BC was unusually potent and contaminated. In some quarters, BC's drug-checking services find more than 80 percent of street opioids contain fentanyl analogs at concentrations the seller didn't disclose.

That supply problem doesn't stop at BC's border. Alberta and the Yukon are the next-most-affected jurisdictions because the BC-supplied product moves east and north along familiar routes. Saskatchewan and Manitoba sit above 20 per 100,000 for the same reason: they're on the pathway, with similar risk-factor profiles in the affected populations.

The east-of-Manitoba pattern is different. Ontario's 14.0 is below the US average. Quebec's 7.2 is below most US states. The Atlantic provinces are lower still. The supply that drives BC's crisis hasn't reached the eastern provinces in the same way — partly distance, partly different upstream networks, partly different prescribed-opioid histories. So when British Columbia drives the national average, it isn't a footnote about how the chart was made. It's the story.

The 2024 decline

The one piece of good news in the data is the year-over-year drop. Canada's rate fell from 20.0 in 2023 to 17.7 in 2024 — the first real annual decline since the federal data series began. Absolute deaths fell by 707. BC's provincial data and partial-year 2025 figures show the same direction.

Whether it lasts is unclear. The supply may have shifted: drug-checking evidence suggests fentanyl concentrations stabilised in some markets in 2024 after years of escalation. Harm-reduction infrastructure — drug checking, supervised consumption, take-home naloxone, prescription alternatives where available — has scaled. And, brutally, the most vulnerable long-term users have already died, leaving a smaller at-risk population. These explanations don't exclude each other. The 2025 full-year data, due around mid-2026, will be the first real test of whether the decline is a trend or a pause.

What this chart is for

For a decade the United States was the implicit benchmark in Canadian opioid-policy debate. "We're not as bad as the US" was a real argument. As of 2024 it no longer survives contact with the data. The right response isn't to flip the chart's headline to "Canada is now worse," because that framing also collapses once you look at the provinces. The right response is to stop organising the discussion around the US altogether, and start organising it around the question that actually matters: what's happening in the five Canadian jurisdictions where the rate is well above any peer country, and what would it take to bring those rates down.